Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 201–300 of 1,001
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
“How, then, can aldosterone, the primary adrenocortical mineralocorticoid, control sodium reabsorption and potassium secretion in the distal nephron, since the free cortisol concentration in plasma is higher than free aldosterone (85, 86)? It turns out that the MRs in the distal tubules of the kidney are protected from…”
Xenobiotic carbonyl reduction and physiological steroid oxidoreduction
Maser, E. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00330-o · Cited by 141
Rogerson, F. M., & Fuller, P. J. (2000) · Steroids · doi:10.1016/s0039-128x(99)00087-2 · Cited by 115
Aldosterone, mineralocorticoid receptors and vascular inflammation
Funder, J. W. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.054 · Cited by 138
Self-citationPascual-Le Tallec, L., Kirsh, O., Lecomte, M.-C., Viengchareun, S., Zennaro, M.-C., Dejean, A., & Lombès, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0299 · Cited by 124
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors
Baker, M. E., Funder, J. W., & Kattoula, S. R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.07.009 · Cited by 138
Self-citationMyocardial fibrosis: role of angiotensin II and aldosterone
Weber, K. T., Brilla, C. G., Campbell, S. E., Eduardo Guarda, S., Zhou, G., & Sriram, K. (1993) · Steinkopff eBooks · doi:10.1007/978-3-642-72497-8_8 · Cited by 137
Chapman, K. E., Coutinho, A. E., Zhang, Z., Kipari, T., Savill, J. S., & Seckl, J. R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.002 · Cited by 120
Funder, J. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.010 · Cited by 137
Self-citationIn Vivo 11β-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice
Ferrari, P., Sansonnens, A., Dick, B., & Frey, F. J. (2001) · Hypertension · doi:10.1161/hy1101.096112 · Cited by 127
“Traditionally, 11 - HSD-2 activity has been assessed by gas-chromatographic assay of the urinary (THF 5 -THF)/THE ratio.16 Recent data suggest that the measurement of UFF and UFE is more sensitive and specific for assessment of renal 11 -HSD-2 activity in vivo.17,18 The present study indicates (1) that intraindividual…”
BackgroundInfluentialLeft Ventricular Fibrosis in Renovascular Hypertensive Rats: Effect of Losartan and Spironolactone
Nicoletti, A., Heudes, D., Hinglais, N., Appay, M., Philippe, M., Sassy-Prigent, C., Bariety, J., & Michel, J. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.101 · Cited by 136
Bienvenu, L. A., Morgan, J., Rickard, A. J., Tesch, G. H., Cranston, G. A., Fletcher, E. K., Delbridge, L. M. D., & Young, M. J. (2012) · Endocrinology · doi:10.1210/en.2011-2098 · Cited by 128
Top‐down and bottom‐up control of stress‐coping
de Kloet, E. R., de Kloet, S. F., de Kloet, C. S., & de Kloet, A. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12675 · Cited by 135
The mineralocorticoid receptor and its coregulators
Yang, J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0031 · Cited by 107
Roland, B. L., Krozowski, Z. S., & Funder, J. W. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03559-p · Cited by 135
Self-citationNapolitano, A., Voice, M. W., Edwards, C. R. W., Seckl, J. R., & Chapman, K. E. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00200-8 · Cited by 133
Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Sandeep, T. C., & Walker, B. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00499-4 · Cited by 133
Strähle, U., Boshart, M., Klock, G., Stewart, F., & Schütz, G. (1989) · Nature · doi:10.1038/339629a0 · Cited by 133
Demyan, W. F. (1992) · Molecular Endocrinology · doi:10.1210/me.6.4.589 · Cited by 117
DNA Methylation and Histone Modification in Hypertension
Stoll, S., Wang, C., & Qiu, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041174 · Cited by 132
“Although cortisol and aldosterone bind mineralocorticoid receptors with similar affinity, degradation of cortisol to cortisone by the HSD11B2 enzyme in mineralocorticoid target tissues ensures that aldosterone is able to bind to the mineralocorticoid receptors [61].”
BackgroundHypothalamus as an Endocrine Organ
Clarke, I. J. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c140019 · Cited by 88
Licorice reduces serum testosterone in healthy women
Armanini, D., Mattarello, M. J., Fiore, C., Bonanni, G., Scaroni, C. M., Sartorato, P., & Palermo, M. (2004) · Steroids · doi:10.1016/j.steroids.2004.09.005 · Cited by 132
Vascular Aldosterone in Genetically Hypertensive Rats
Takeda, Y., Miyamori, I., Inaba, S., Furukawa, K., Hatakeyama, H., Yoneda, T., Mabuchi, H., & Takeda, R. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.45 · Cited by 132
Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., & Bahr, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460789 · Cited by 130
“This enzyme-mediated specificity of hMR was first described by Funder et al. (11) and Edwards et al. in 1988 (12). Progesterone shows a high affinity for hMR, but confers only a weak transactivation activity and is, therefore, an MC antagonist (13 –15). During the luteal phase of the menstrual cycle, progesterone plas…”
InfluentialLiquorice and its health implications
Olukoga, A. O., & Donaldson, D. I. (2000) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400012000203 · Cited by 130
“O HSD to modulate access of ligands to glucocorticoid and mineralocorticoid receptors (Funder et al, 1988; Edwards etal, 1988; Monder, 1991).”
BackgroundC/EBP Regulates Hepatic Transcription of 11β-Hydroxysteroid Dehydrogenase Type 1
Williams, L. J. S., Lyons, V., MacLeod, I., Rajan, V., Darlington, G. J., Poli, V., Seckl, J. R., & Chapman, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001286200 · Cited by 115
Ecto-enzymes: physiology meets pathology
Goding, J. W. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.3.285 · Cited by 116
“It has been used by nature to impose selective mineralocorticoid responsiveness by cells that also possess the receptor for glucocorticoids [10] [11] [12] , and there is every reason to think that it might apply in other systems.”
BackgroundImmunolocalization of gluco- and mineralocorticoid receptors in rabbit kidney
Farman, N., Oblin, M. E., Lombes, M., Delahaye, F., Westphal, H. M., Bonvalet, J. P., & Gasc, J. M. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.260.2.c226 · Cited by 119
Kushnir, M. M., Neilson, R., Roberts, W. L., & Rockwood, A. L. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.005 · Cited by 129
The Influence of Glycyrrhetinic Acid on Plasma Cortisol and Cortisone in Healthy Young Volunteers
MACKENZIE, M. A., HOEFNAGELS, W. H. L., JANSEN, R. W. M. M., BENRAAD, T. J., & KLOPPENBORG, P. W. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1637 · Cited by 121
Regulation of Transport in the Connecting Tubule and Cortical Collecting Duct
Staruschenko, A. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110052 · Cited by 128
Glucocorticoid metabolism and reproduction: a tale of two enzymes
Michael, A. E., Thurston, L. M., & Rae, M. (2003) · Reproduction · doi:10.1530/rep.0.1260425 · Cited by 128
“As glucocorticoids circulate at concentrations 1000-fold higher than aldosterone, the mineralocorticoid receptors are hyperstimulated, resulting in excessive sodium transport and significant changes in sodium-dependent fluid fluxes (Funder et al., 1988).”
Background11β-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain
Robson, A. C., Leckie, C. M., Seckl, J. R., & Holmes, M. C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00161-2 · Cited by 128
Kwak, S. P. (1993) · Endocrinology · doi:10.1210/en.133.5.2344 · Cited by 111
Primary aldosteronism: an update on screening, diagnosis and treatment
Rossi, G. P., Pessina, A. C., & Heagerty, A. M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4b3e6 · Cited by 120
Zennaro, M., Souque, A., Viengchareun, S., Poisson, E., & Lombès, M. (2001) · Molecular Endocrinology · doi:10.1210/me.15.9.1586 · Cited by 112
Impaired Regulation of Renal K+ Elimination in the sgk1-Knockout Mouse
Huang, D. Y., Wulff, P., Völkl, H., Loffing, J., Richter, K., Kuhl, D., Lang, F., & Vallon, V. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000120368.59693.a8 · Cited by 125
Pereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 126
Stress at the Synapse: Signal Transduction Mechanisms of Adrenal Steroids at Neuronal Membranes
Prager, E. M., & Johnson, L. R. (2009) · Science Signaling · doi:10.1126/scisignal.286re5 · Cited by 113
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation
Young, M. J. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f56854 · Cited by 125
Liu, Y., Nakagawa, Y., Wang, Y., Sakurai, R., Tripathi, P. V., Lutfy, K., & Friedman, T. C. (2005) · Diabetes · doi:10.2337/diabetes.54.1.32 · Cited by 111
Sato, A., & Funder, J. W. (1996) · Endocrinology · doi:10.1210/en.137.10.4145 · Cited by 118
Self-citationType 2 11β-hydroxysteroid dehydrogenase in foetal and adult life
Stewart, P. M., Whorwood, C. B., & Mason, J. I. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00195-6 · Cited by 124
The Hypothalamic-Pituitary-Adrenal Axis: A Brief History
Miller, W. L. (2018) · Hormone Research in Paediatrics · doi:10.1159/000487755 · Cited by 124
Impairment of Sodium Balance in Mice Deficient in Renal Principal Cell Mineralocorticoid Receptor
Ronzaud, C., Loffing, J., Bleich, M., Gretz, N., Gröne, H., Schütz, G., & Berger, S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090975 · Cited by 124
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 124
Rafestin-Oblin, M.-E., Souque, A., Bocchi, B., Pinon, G., Fagart, J., & Vandewalle, A. (2003) · Endocrinology · doi:10.1210/en.2002-220708 · Cited by 113
6 Mineralocorticoid resistance
Komesaroff, P. A., Funder, J. W., & Fuller, P. J. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80256-3 · Cited by 123
Self-citationOzols, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2305 · Cited by 115
The Ubiquitous Mineralocorticoid Receptor: Clinical Implications
Hawkins, U. A., Gomez-Sanchez, E. P., Gomez-Sanchez, C. M., & Gomez-Sanchez, C. E. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0297-0 · Cited by 112
“Specificity of the MR for aldosterone in transporting epithelia was found to be due to the co-expression of an enzyme, 11β-hydroxysteroid dehydrogenase 2 (11βHSD2), which metabolizes the active glucocorticoids cortisol and corticosterone to the inactive metabolites cortisone and 11-dehydrocorticosterone [21–23].”
Pharmacology of glucocorticoids: Beyond receptors
van der Laan, S., & Meijer, O. C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.060 · Cited by 119
Corticosteroid receptors in the brain: gene targeting studies
Kellendonk, C., Gass, P., Kretz, O., Schütz, G., & Tronche, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00638-4 · Cited by 121
“In contrast, in mineralocorticoidresponsive tissues, such as the kidney, a specific activation of MR by aldosterone is ensured through enzymatic inactivation of glucocorticoids [24].”
BackgroundCorticosteroid receptors, macrophages and cardiovascular disease
Rickard, A. J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0144 · Cited by 118
Evolution of adrenal and sex steroid action in vertebrates: a ligand‐based mechanism for complexity
Baker, M. E. (2003) · BioEssays · doi:10.1002/bies.10252 · Cited by 109
“Flexibility and complexity in vertebrate differentiation and development also arises from temporal and tissue-specific expression of enzymes that metabolize steroids [12-17].”
BackgroundCorticosteroids and vascular tone: mapping the messenger maze
Walker, B. R., & Williams, B. C. (1992) · Clinical Science · doi:10.1042/cs0820597 · Cited by 112
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
“The mineralocorticoid receptor is actually a promiscuous receptor if not protected by 11β-steroid dehydrogenase type 2, as it occurs in the kidney (Funder et al., 1988; Edwards et al., 1988).”
BackgroundTherapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 99
“Rather, it was shown that 11-HSD activity was essential for maintaining aldosterone selectivity of MR (Edwards et al., 1988; Funder et al., 1988).”
BackgroundPitt, B. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.009 · Cited by 117
Tyr-179 and Lys-183 are essential for enzymatic activity of 11β-hydroxysteroid dehydrogenase
Obeid, J., & White, P. C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92373-6 · Cited by 116
Mechanisms of ligand specificity of the mineralocorticoid receptor
Fuller, P. J., Yao, Y., Yang, J., & Young, M. J. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0372 · Cited by 116
“In the case of the MR, the work of both Edwards et al. (1988) and Funder et al. (1988) over 20 years ago clearly established that in epithelial tissues, access of aldosterone and a lack of access of cortisol to the MR were determined by the enzyme 11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2).”
MethodDiederich, S., Grossmann, C., Hanke, B., Quinkler, M., Herrmann, M., Bahr, V, & Oelkers, W. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420200 · Cited by 102
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
Funder, J. W. (2010) · Endocrinology · doi:10.1210/en.2010-0465 · Cited by 100
Self-citationMineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
Funder, J. W. (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s13783 · Cited by 115
“Over two decades ago, it was proposed that this otherwise overwhelming concentration difference was nullified by high levels of coexpression of the enzyme 11βhydroxysteroid dehydrogenase (11βHSD2), which converts cortisol to receptor-inactive cortisone.(9,10) Although it is still widely taught that this enzyme operate…”
Self-citationCo-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors
Baker, M. E. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.007 · Cited by 113
“However, research on steroidogenic and steroid-inactivating enzymes increased, after it was realized that local expression of steroidogenic and steroid-inactivating enzymes has a key role in steroid hormone action (Funder et al., 1988; Edwards et al., 1996).”
BackgroundBiochemistry and Reproductive Endocrinology of Estrogen Sulfotransferase
Song, W. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03985.x · Cited by 113
Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
Bene, N. C., Alcaide, P., Wortis, H. H., & Jaffe, I. Z. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.005 · Cited by 112
“Some non-epithelial cells, including vascular smooth muscle and endothelial cells, appear to express 11b-HSD2 and hence are thought to be aldosterone-responsive [9,10], while cardiomyocytes do not and hence cortisol may be the cardiac MR ligand [18].”
Aldosterone-sensitive neurons in the nucleus of the solitary tract: Efferent projections
Geerling, J. C., & Loewy, A. D. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20993 · Cited by 111
“…enzyme is restricted to specialized aldosterone-sensitive cells in a limited number of epithelial tissues such as the distal nephron of the kidney; it makes a cell sensitive to aldosterone via prereceptor inactivation of other adrenal steroids (Funder et al., 1988; Naray-Fejes-Toth et al., 1998).”
BackgroundAldosterone as a Cardiovascular Risk Factor
Yoo, S. J. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.1.8 · Cited by 112
VAN DEN BERG, D. T. W. M., DE KLOET, E. R., VAN DIJKEN, H. H., & DE JONG, W. (1990) · Endocrinology · doi:10.1210/endo-126-1-118 · Cited by 112
Whorwood, C. B., Mason, J. I., Ricketts, M., Howie, A. J., & Stewart, P. M. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03546-j · Cited by 110
Whorwood, C. B., Franklyn, J. A., Sheppard, M. C., & Stewart, P. M. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90220-d · Cited by 111
11β‐hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation
SECKL, J. R. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00720.x · Cited by 105
DuPont, J. J., & Jaffe, I. Z. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0009 · Cited by 110
Epigenetics and arterial hypertension: the challenge of emerging evidence
Friso, S., Carvajal, C. A., Fardella, C., & Olivieri, O. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.007 · Cited by 111
Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess
Li, A., Tedde, R., Krozowski, Z., Pala, A., Li, K. X. Z., Shackleton, C. H. L., Mantero, F., Palermo, M., & Stewart, P. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301955 · Cited by 109
Nongenomic actions of steroid hormones
Wehling, M. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90165-1 · Cited by 110
Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone.
Miller, A. H., Spencer, R. L., Stein, M., & McEwen, B. S. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.3.e405 · Cited by 89
Zhang, M., Xu, J., Yao, B., Yin, H., Cai, Q., Shrubsole, M. J., Chen, X., Kon, V., Zheng, W., Pozzi, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37398 · Cited by 109
“Normally, 11β–hydroxysteroid dehydrogenase type II (11βHSD2) inactivates intracellular glucocorticoids in the classic mineralocorticoid-responsive organs, kidney and intestine (particularly colon), in order to maintain the specificity of the mineralocorticoid receptor to activation by aldosterone (17).”
Kidney Injury From Alternative Medicines
Colson, C. R. D., & Broe, M. E. D. (2005) · Advances in Chronic Kidney Disease · doi:10.1016/j.ackd.2005.03.006 · Cited by 109
Localization of thiazide-sensitive Na+-Cl−cotransport and associated gene products in mouse DCT
Câmpean, V., Kricke, J., Ellison, D., Luft, F. C., & Bachmann, S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0148.2001 · Cited by 105
“The typical target cells are the principal cells of the collecting duct (9, 10).”
BackgroundRUNDLE, S. E., FUNDER, J. W., LAKSHMI, V., & MONDER, C. (1989) · Endocrinology · doi:10.1210/endo-125-3-1700 · Cited by 105
Self-citationKitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101
“While these different physiological actions may partially depend on the enzymatic activity of 11 -hydroxysteroid dehydrogenase type 2 (11 HSD2), which inactivates hydrocortisone (glucocorticoid) and results in the preferential activation of MR by aldosterone in target tissues (15), this does not explain the distinct p…”
BackgroundRetractedPresence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear
Rarey, K. E., & Luttge, W. G. (1989) · Hearing Research · doi:10.1016/0378-5955(89)90013-0 · Cited by 107
Kolber, B. J., Wieczorek, L., & Muglia, L. J. (2008) · Stress · doi:10.1080/10253890701821081 · Cited by 106
“Specifically, within peripheral tissues, such as the tight epithelia in kidney and colon, only aldosterone can activate MR as glucocorticoids are enzymatically converted in these tissues by 11 b-hydroxysteroid dehydrogenase Type II to inactive metabolites (cortisol to cortisone, corticosterone to 11-dehydrocorticoster…”
BackgroundBosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 106
Aldosterone and d -Glucose Stimulate the Proliferation of Human Cardiac Myofibroblasts In Vitro
Neumann, S., Huse, K., Semrau, R., Diegeler, A., Gebhardt, R., Buniatian, G. H., & Scholz, G. H. (2002) · Hypertension · doi:10.1161/hy0302.105295 · Cited by 99
Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
Ferrari, P., & Krozowski, Z. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00978.x · Cited by 106
“dtd" [ ]> The 11b-hydroxysteroid dehydrogenase (11bHSD) is a microsomal enzyme responsible for the interconversion of active 11-hydroxy-glucocorticoids to their receptor inactive 11-keto-metabolites, while the hemiacetal group of aldosterone renders this steroid a poor substrate for the enzyme Figure 1”
BackgroundIs aldosterone bad for the heart?
Funder, J. W. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.006 · Cited by 106
Self-citationThe short-chain alcohol dehydrogenase superfamily: Variations on a common theme
Krozowski, Z. S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90084-1 · Cited by 106
Labombarda, F., Pianos, A., Liere, P., Eychenne, B., Gonzalez, S., Cambourg, A., De Nicola, A. F., Schumacher, M., & Guennoun, R. (2006) · Endocrinology · doi:10.1210/en.2005-0955 · Cited by 94
Latif, S. A., Conca, T. J., & Morris, D. J. (1990) · Steroids · doi:10.1016/0039-128x(90)90024-6 · Cited by 105
Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct
Schafer, J. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2002 · Cited by 104
Liu, Y., Mladinov, D., Pietrusz, J. L., Usa, K., & Liang, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn231 · Cited by 91
“It is widely accepted that 11b-HSD2 in the distal nephron of the kidney is critical for preventing the activation of mineralocorticoid receptors by glucocorticoids.(11,36) The finding in this study suggests that 11b-HSD isoforms might also play an important role in controlling effects of cortisol in the vasculature.”
BackgroundMaser, E., Völker, B., & Friebertshäuser, J. (2002) · Biochemistry · doi:10.1021/bi015803t · Cited by 82
Baker, M. E., & Katsu, Y. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0661 · Cited by 103
“Moreover, as discussed below, it appears that replacement of methionine with serine was important in the loss transcriptional activation of the MR by Prog (Geller et al. 2000) and cortisone (Rafestin-Oblin et al. 2003).”
InfluentialRothuizen, J. J., Reul, J. M. H. M., van Sluijs, F. J., Mol, J. A., Rijnberk, A., & de Kloet, E. R. (1993) · Endocrinology · doi:10.1210/en.132.1.161 · Cited by 93
Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies
Myles, K., & Funder, J. W. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e601 · Cited by 102
Self-citation11β-Hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily
Krozowski, Z. S. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90064-d · Cited by 102
Cole, T. J., Myles, K., Purton, J. F., Brereton, P. S., Solomon, N. M., Godfrey, D. I., & Funder, J. W. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00407-x · Cited by 101
Self-citationPlacental 11β-hydroxysteroid dehydrogenase and the programming of hypertension
Seckl, J. R., Benediktsson, R., Lindsay, R. S., & Brown, R. W. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00193-x · Cited by 102
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.